You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells
|
---|---|
Published in |
BMC Cancer, May 2007
|
DOI | 10.1186/1471-2407-7-80 |
Pubmed ID | |
Authors |
Javier A Menendez, Alejandro Vazquez-Martin, Ramon Colomer, Joan Brunet, Alegria Carrasco-Pancorbo, Rocio Garcia-Villalba, Alberto Fernandez-Gutierrez, Antonio Segura-Carretero |
Abstract |
A low incidence of breast cancer in the Mediterranean basin suggests that a high consumption of Extra Virgin Olive Oil (EVOO) might confer this benefit. While the anti-HER2 oncogene effects of the main omega-9 fatty acid present in EVOO triacylglycerols (i.e., oleic acid) have been recently described, the anti-breast cancer activities of EVOO non-glyceridic constituents--which consist of at least 30 phenolic compounds--remained to be evaluated. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 2% |
United States | 2 | 2% |
Japan | 1 | <1% |
Italy | 1 | <1% |
Unknown | 114 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 26 | 22% |
Student > Master | 19 | 16% |
Student > Ph. D. Student | 17 | 14% |
Student > Bachelor | 9 | 8% |
Professor > Associate Professor | 8 | 7% |
Other | 19 | 16% |
Unknown | 22 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 31 | 26% |
Biochemistry, Genetics and Molecular Biology | 14 | 12% |
Medicine and Dentistry | 12 | 10% |
Chemistry | 9 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 6% |
Other | 17 | 14% |
Unknown | 30 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2022.
All research outputs
#2,436,159
of 23,003,906 outputs
Outputs from BMC Cancer
#470
of 8,357 outputs
Outputs of similar age
#5,533
of 72,368 outputs
Outputs of similar age from BMC Cancer
#4
of 15 outputs
Altmetric has tracked 23,003,906 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,357 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 72,368 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.